Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished up +0.057% to 7,519.20.
The Resmed CDI (ASX: RMD) share price has been a star performer on the ASX recently. Here are just two ways I look at ResMed.
Global healthcare leader Resmed CDI (ASX: RMD) recorded a 14% increase in quarterly sales upon “incredible demand” and a competitor recall.
Here you go: A $50,000 per year passive income special report
Join more 50,000 Australian investors who read our weekly investing newsletter and we’ll send you our passive income investing report right now.
Simply enter your email address and we’ll send it to you. No tricks. Unsubscribe anytime.
Unsubscribe anytime. Read our Terms, Financial Services Guide, Privacy Policy. We’ll never sell your email address. Our company is Australian owned.
